Latest Amidines Stories
Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered uncontrollable internal bleeding or other serious injuries allegedly due to their use of the blood thinner.
All Aspects Of Litigation Surrounding The Federal Pradaxa Lawsuits Alleging Boehringer Ingelheim's Blood Thinner Caused Serious Internal Bleeding Have Been Suspended Until Completion Of A
Thousands of Pradaxa Lawsuits Currently Pending in U.S.
Reports of Xarelto Bleeding Mounts As Doctors Are Prescribing Xarelto Over Pradaxa and Seeing a Rise In Adverse Events While Xarelto Lawsuits Begin to be Filed Reports Wright & Schulte LLC
Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, notes that Xarelto® is surpassing Pradaxa® in the number of reported adverse events, according to the Institute for Safe
A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer
Boehringer Ingelheim Agrees to Pay $650 Million To Settle 4,000 Pradaxa Lawsuit That Allege Internal Bleeding After Taking The Prescription Medication. Columbus,
The Firm is evaluating Pradaxa bleeding claims on behalf of individuals who allegedly suffered life-threatening episodes of internal hemorrhaging due to their use of Pradaxa. New
Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to announce that earlier today Boehringer Ingelheim Pharmaceuticals, Inc.
- Growing in low tufty patches.